| For: | Pirola CJ, Sookoian S. Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity. World J Gastroenterol 2018; 24(15): 1601-1615 [PMID: 29686467 DOI: 10.3748/wjg.v24.i15.1601] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i15/1601.htm |
| Number | Citing Articles |
| 1 |
Vanessa D. de Mello, Ratika Sehgal, Ville Männistö, Anton Klåvus, Emma Nilsson, Alexander Perfilyev, Dorota Kaminska, Zong Miao, Päivi Pajukanta, Charlotte Ling, Kati Hanhineva, Jussi Pihlajamäki. Serum aromatic and branched‐chain amino acids associated with NASH demonstrate divergent associations with serum lipids. Liver International 2021; 41(4) doi: 10.1111/liv.14743
|
| 2 |
Moongi Ji, Yunju Jo, Seung Joon Choi, Seong Min Kim, Kyoung Kon Kim, Byung-Chul Oh, Dongryeol Ryu, Man-Jeong Paik, Dae Ho Lee. Plasma Metabolomics and Machine Learning-Driven Novel Diagnostic Signature for Non-Alcoholic Steatohepatitis. Biomedicines 2022; 10(7) doi: 10.3390/biomedicines10071669
|
| 3 |
Cheng Hu, Weiping Jia, Jiarui Wu. Multi-omics profiling: the way toward precision medicine in metabolic diseases. Journal of Molecular Cell Biology 2021; doi: 10.1093/jmcb/mjab051
|
| 4 |
Carlos J. Pirola, Silvia Sookoian. COVID‐19 and non‐alcoholic fatty liver disease: Biological insights from multi‐omics data. Liver International 2023; 43(3) doi: 10.1111/liv.15509
|
| 5 |
Line O. Elingaard-Larsen, Sofie O. Villumsen, Louise Justesen, Anne Cathrine B. Thuesen, Min Kim, Mina Ali, Else R. Danielsen, Cristina Legido-Quigley, Gerrit van Hall, Torben Hansen, Tarunveer S. Ahluwalia, Allan A. Vaag, Charlotte Brøns. Circulating Metabolomic and Lipidomic Signatures Identify a Type 2 Diabetes Risk Profile in Low-Birth-Weight Men with Non-Alcoholic Fatty Liver Disease. Nutrients 2023; 15(7) doi: 10.3390/nu15071590
|
| 6 |
Lucia Carulli, Giulia Zanca, Filippo Schepis, Erica Villa. RETRACTED: The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019; 9(2) doi: 10.3390/metabo9020025
|
| 7 |
Sarthak Sahoo, Divyoj Singh, Priyanka Chakraborty, Mohit Kumar Jolly. Emergent Properties of the HNF4α-PPARγ Network May Drive Consequent Phenotypic Plasticity in NAFLD. Journal of Clinical Medicine 2020; 9(3) doi: 10.3390/jcm9030870
|
| 8 |
Tzung Cheng Ye, Shu-Ju Chao, Chihpin Huang, Ru-Tsun Mai. Aggravated liver steatosis in a modern dietary mouse model via long-term treatment of SiO2 nanoparticles in drinking water. Sustainable Environment Research 2024; 34(1) doi: 10.1186/s42834-024-00237-7
|
| 9 |
Ali Şenol, Alparslan Kadir Devrim, Miyase Çinar, Mahmut Sözmen, Fatma Betül Akça. Biochemical and Molecular Insights Into Monocrotaline‐Induced Hepatotoxicity: An Experimental Mouse Study. Journal of Applied Toxicology 2026; doi: 10.1002/jat.70292
|
| 10 |
Debjyoti Kundu, Lindsey Kennedy, Tianhao Zhou, Burcin Ekser, Vik Meadows, Amelia Sybenga, Konstantina Kyritsi, Lixian Chen, Ludovica Ceci, Nan Wu, Chaodong Wu, Shannon Glaser, Guido Carpino, Paolo Onori, Eugenio Gaudio, Gianfranco Alpini, Heather Francis. p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling. Hepatology 2023; 78(1) doi: 10.1097/HEP.0000000000000307
|
| 11 |
Andrew S. Perry, Niran Hadad, Emeli Chatterjee, Maria Jimenez-Ramos, Eric Farber-Eger, Rashedeh Roshani, Lindsey K. Stolze, Michael J. Betti, Shilin Zhao, Shi Huang, Liesbet Martens, Timothy J. Kendall, Tinne Thone, Kaushik Amancherla, Samuel Bailin, Curtis L. Gabriel, John Koethe, J. Jeffrey Carr, James Greg Terry, Nataraja Sarma Vaitinadin, Jane E. Freedman, Kahraman Tanriverdi, Eric Alsop, Kendall Van Keuren-Jensen, John F.K. Sauld, Gautam Mahajan, Sadiya S. Khan, Laura Colangelo, Matthew Nayor, Susan Fisher-Hoch, Joseph B. McCormick, Kari E. North, Jennifer E. Below, Quinn S. Wells, E. Dale Abel, Ravi Kalhan, Charlotte Scott, Martin Guilliams, Eric R. Gamazon, Jonathan A. Fallowfield, Nicholas E. Banovich, Saumya Das, Ravi Shah. A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver. Cell Reports Medicine 2024; 5(12) doi: 10.1016/j.xcrm.2024.101871
|
| 12 |
Manuel Romero-Gómez, Javier Escalada, Mar Noguerol, Antonio Pérez, Juana Carretero, Javier Crespo, Juan J. Mascort, Ignacio Aguilar, Francisco Tinahones, Pedro Cañones, Ricardo Gómez-Huelgas, Daniel de Luis, Idoia Genúa Trullos, Rocío Aller, Miguel A. Rubio. Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis. Gastroenterología y Hepatología (English Edition) 2025; 48(8) doi: 10.1016/j.gastre.2025.502442
|
| 13 |
Feiwei Cao, Qinchao Ding, Hui Zhuge, Shanglei Lai, Kaixin Chang, Chunyan Le, Guorong Yang, Teresa G. Valencak, Songtao Li, Daxi Ren. Lactobacillus plantarum ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota. Frontiers in Nutrition 2023; 9 doi: 10.3389/fnut.2022.1071284
|
| 14 |
Anna Migni, Desirée Bartolini, Maria Rachele Ceccarini, Chiara Galli, Gina Cavaliere, Stefano Garetto, Jacopo Lucci, Francesco Galli. Nutrigenomics of fat-soluble vitamins and micronutrients in hepatocyte lipotoxicity and MASLD. Progress in Lipid Research 2026; 101 doi: 10.1016/j.plipres.2026.101380
|
| 15 |
Amedeo Lonardo, Juan Pablo Arab, Marco Arrese. Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management. Advances in Therapy 2021; 38(5) doi: 10.1007/s12325-021-01690-1
|
| 16 |
Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur, Angeliki M. Angelidi. Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. Diagnostics 2022; 12(2) doi: 10.3390/diagnostics12020407
|
| 17 |
Li-Hong Fan, Wei Wu. Research status and hotspots in the field of hyperlipidemia and metabolism: A bibliometric study. Medicine 2025; 104(28) doi: 10.1097/MD.0000000000043183
|
| 18 |
Manuel Romero-Gómez, Javier Escalada, Mar Noguerol, Antonio Pérez, Juana Carretero, Javier Crespo, Juan J. Mascort, Ignacio Aguilar, Francisco Tinahones, Pedro Cañones, Ricardo Gómez-Huelgas, Daniel de Luis, Idoia Genúa Trullos, Rocío Aller, Miguel A. Rubio, José Luis Calleja. Corrigendum. Guía de práctica clínica multidisciplinar de manejo de la esteatosis hepática metabólica. Gastroenterología y Hepatología 2026; 49(5) doi: 10.1016/j.gastrohep.2025.502639
|
| 19 |
Mohammed Eslam, Arun J. Sanyal, Jacob George, Arun Sanyal, Brent Neuschwander-Tetri, Claudio Tiribelli, David E. Kleiner, Elizabeth Brunt, Elisabetta Bugianesi, Hannele Yki-Järvinen, Henning Grønbæk, Helena Cortez-Pinto, Jacob George, Jiangao Fan, Luca Valenti, Manal Abdelmalek, Manuel Romero-Gomez, Mary Rinella, Marco Arrese, Mohammed Eslam, Pierre Bedossa, Philip N. Newsome, Quentin M. Anstee, Rajiv Jalan, Ramon Bataller, Rohit Loomba, Silvia Sookoian, Shiv K. Sarin, Stephen Harrison, Takumi Kawaguchi, Vincent Wai-Sun Wong, Vlad Ratziu, Yusuf Yilmaz, Zobair Younossi. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology 2020; 158(7) doi: 10.1053/j.gastro.2019.11.312
|
| 20 |
Simona Riccio, Rosa Melone, Caterina Vitulano, Pierfrancesco Guida, Ivan Maddaluno, Stefano Guarino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics. World Journal of Clinical Pediatrics 2022; 11(3): 221-238 doi: 10.5409/wjcp.v11.i3.221
|
| 21 |
Hiroyuki Yamamoto, Naoto Uramaru, Azusa Kawashima, Toshiyuki Higuchi, Sandro Sonnino. Carbonic anhydrase 3 increases during liver adipogenesis even in pre‐obesity, and its inhibitors reduce liver adipose accumulation. FEBS Open Bio 2022; 12(4) doi: 10.1002/2211-5463.13376
|
| 22 |
Yutong Sun, Xingyu Wang, Hongzhi Liu, Xinbo Zhou, Qingquan Ma. Preventive and Ameliorative Effects of Alanine Supplementation on High-Fat Diet–Induced Obesity and Metabolic Dysfunction via the Gut–Liver–Adipose Axis in C57BL/6J Mice. Foods 2026; 15(5) doi: 10.3390/foods15050806
|
| 23 |
Sònia Torres, Sara Samino, Pere Ràfols, Manuela Martins-Green, Xavier Correig, Noelia Ramírez. Unravelling the metabolic alterations of liver damage induced by thirdhand smoke. Environment International 2021; 146 doi: 10.1016/j.envint.2020.106242
|
| 24 |
Gwyneth Soon, Aileen Wee. Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective. Clinical and Molecular Hepatology 2021; 27(1) doi: 10.3350/cmh.2020.0181
|
| 25 |
Rohitash Jamwal, Benjamin J. Barlock. Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes. Pharmaceuticals 2020; 13(9) doi: 10.3390/ph13090222
|
| 26 |
Farzaneh Iravani, Neda Hosseini, Majid Mojarrad. Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Middle East Journal of Digestive Diseases 2018; 10(4) doi: 10.15171/mejdd.2018.113
|
| 27 |
Yong-yu Yang, Li Xie, Ning-ping Zhang, Da Zhou, Tao-tao Liu, Jian Wu. Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis. Acta Pharmacologica Sinica 2022; 43(5) doi: 10.1038/s41401-022-00860-3
|
| 28 |
Alia Hadefi, Delphine Degré, Eric Trépo, Christophe Moreno. Noninvasive diagnosis in alcohol‐related liver disease. Health Science Reports 2020; 3(1) doi: 10.1002/hsr2.146
|
| 29 |
Carlos Benítez, Juan Pablo Arab, Francisco Barrera, Jesus M. Banales, Marco Arrese. NAFLD and NASH. 2020; doi: 10.1007/978-3-030-37173-9_13
|
| 30 |
Aleksandra Klisic, Ratko Tomašević, Slavko Djuraskovic, Filiz Mercantepe, Ana Ninic. Biomarkers for early identification of metabolic dysfunction-associated steatotic liver disease (MASLD): a narrative review. Archives of Medical Science 2026; doi: 10.5114/aoms/219846
|
| 31 |
Carlos J. Pirola, Silvia Sookoian. Personalized medicine in nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 2022; 28(4) doi: 10.3350/cmh.2022.0175
|
| 32 |
Pinggui Lei, Na Hu, Yuhui Wu, Maowen Tang, Chong Lin, Luoyi Kong, Lingfeng Zhang, Peng Luo, Lawrence Wing‐Chi Chan. Radiobioinformatics: A novel bridge between basic research and clinical practice for clinical decision support in diffuse liver diseases. iRADIOLOGY 2023; 1(2) doi: 10.1002/ird3.24
|
| 33 |
Manuel Suárez, Núria Canela, Josep M. del Bas, Francesc Puiggròs, Lluís Arola, Antoni Caimari. Comprehensive Foodomics. 2021; doi: 10.1016/B978-0-08-100596-5.22826-6
|
| 34 |
Cheng Hu, Tao Wang, Xiaoyu Zhuang, Qiaoli Sun, Xiaochun Wang, Hui Lin, Mingli Feng, Jiaqi Zhang, Qin Cao, Yuanye Jiang. Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02820-7
|
| 35 |
Mingzhu Wu, Shucong Chen, Wencheng Guo, Sijia Gu, Keyi Li, Yumeng Shi, Yu Qian, Yulian Sun, Yarui Liu, Hongkai Zhu. Pre-existing liver dysfunction modulates di-(2-ethylhexyl) phthalate (DEHP)-associated biological responses through host-microbiome networks. Environmental Pollution 2026; 404 doi: 10.1016/j.envpol.2026.128417
|
| 36 |
Noemí Cabré, Fedra Luciano‐Mateo, Gerard Baiges‐Gayà, Salvador Fernández‐Arroyo, Elisabet Rodríguez‐Tomàs, Anna Hernández‐Aguilera, Marta París, Fàtima Sabench, Daniel Del Castillo, José López‐Miranda, Javier A. Menéndez, Jordi Camps, Jorge Joven. Plasma metabolic alterations in patients with severe obesity and non‐alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics 2020; 51(3) doi: 10.1111/apt.15606
|
| 37 |
Mariana Ponce-de-Leon, Anke Hannemann, Jakob Linseisen, Matthias Nauck, Markus M. Lerch, Robin Bülow, Henry Völzke, Nele Friedrich, Jan Kassubek, Hans-Peter Müller, Sebastian-Edgar Baumeister, Christa Meisinger. Links between ectopic and abdominal fat and systemic inflammation: New insights from the SHIP-Trend study. Digestive and Liver Disease 2022; 54(8) doi: 10.1016/j.dld.2022.02.003
|
| 38 |
Alimire Abulikemu, Xinying Zhao, Hailin Xu, Yan Li, Ru Ma, Qing Yao, Ji Wang, Zhiwei Sun, Yanbo Li, Caixia Guo. Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stress. Redox Biology 2023; 59 doi: 10.1016/j.redox.2022.102569
|
| 39 |
Shelly C Lu, Mazen Noureddin, Cristina Alonso, José M Mato. Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2019; 25(24): 3009-3020 doi: 10.3748/wjg.v25.i24.3009
|
| 40 |
Elisa Gurian, Pablo Giraudi, Natalia Rosso, Claudio Tiribelli, Deborah Bonazza, Fabrizio Zanconati, Michela Giuricin, Silvia Palmisano, Nicolò de Manzini, Valter Sergo, Alois Bonifacio. Differentiation between stages of non-alcoholic fatty liver diseases using surface-enhanced Raman spectroscopy. Analytica Chimica Acta 2020; 1110 doi: 10.1016/j.aca.2020.02.040
|
| 41 |
Carlos A. Vaccaro, Walter Pavicic, Adrián Gadano, Marcelo Risk, Marcelo Figar, Susana Llesuy, Tamara Piñero, Julieta Trinks, Valeria Burgos, Flavia Mazzini, Jorge Alberbide, Ana Basquiera, Marcela Bolontrade, María Isabel Giménez, Federico Jauk, Julieta Argüero. Investigación traslacional en microbioma (intramic): un área de interés común y creciente en el imtib, hospital italiano e instituto universitario. Revista del Hospital Italiano de Buenos Aires 2020; 40(1) doi: 10.51987/Rev.Hosp.Ital.B.Aires.v40i1.492
|
| 42 |
Alanah Pieters, Eva Gijbels, Bruno Cogliati, Pieter Annaert, Lindsey Devisscher, Mathieu Vinken. Biomarkers of Cholestasis. Biomarkers in Medicine 2021; 15(6) doi: 10.2217/bmm-2020-0691
|
| 43 |
Silvia Sookoian, Carlos J. Pirola. Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology. Clinical and Molecular Hepatology 2020; 26(4) doi: 10.3350/cmh.2020.0136
|
| 44 |
Carlos J. Pirola, Silvia Sookoian. The lipidome in nonalcoholic fatty liver disease: actionable targets. Journal of Lipid Research 2021; 62 doi: 10.1016/j.jlr.2021.100073
|
| 45 |
Min-Ae Song, Thomas Ernst, Maarit Tiirikainen, Jörg Tost, Lynne R. Wilkens, Linda Chang, Laurence N. Kolonel, Loïc Le Marchand, Unhee Lim. Methylation of imprintedIGF2regions is associated with total, visceral, and hepatic adiposity in postmenopausal women. Epigenetics 2018; 13(8) doi: 10.1080/15592294.2018.1518100
|
| 46 |
Juqiang Han, Xiang Zhang. Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.653293
|
| 47 |
José F. Català-Senent, Marta R. Hidalgo, Marina Berenguer, Gopanandan Parthasarathy, Harmeet Malhi, Pablo Malmierca-Merlo, María de la Iglesia-Vayá, Francisco García-García. Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies. Biology of Sex Differences 2021; 12(1) doi: 10.1186/s13293-021-00368-1
|
| 48 |
Urho M. Kujala, Jani P. Vaara, Heikki Kainulainen, Tommi Vasankari, Elina Vaara, Heikki Kyröläinen. Associations of Aerobic Fitness and Maximal Muscular Strength With Metabolites in Young Men. JAMA Network Open 2019; 2(8) doi: 10.1001/jamanetworkopen.2019.8265
|
| 49 |
Carlos J Pirola, Silvia Sookoian. Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making. Expert Review of Gastroenterology & Hepatology 2023; 17(4) doi: 10.1080/17474124.2023.2191190
|
| 50 |
Laurent Castera, Mireen Friedrich-Rust, Rohit Loomba. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 2019; 156(5) doi: 10.1053/j.gastro.2018.12.036
|
| 51 |
Silvia Sookoian, Carlos J. Pirola, Luca Valenti, Nicholas O. Davidson. Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology. Hepatology 2020; 72(1) doi: 10.1002/hep.31229
|
| 52 |
Leticia Lacalle-Bergeron, David Izquierdo-Sandoval, Alfredo Fernández-Quintela, María P. Portillo, Juan Vicente Sancho, Félix Hernández, Tania Portolés. LC-IMS-HRMS for identification of biomarkers in untargeted metabolomics: The effects of pterostilbene and resveratrol consumption in liver steatosis, animal model. Food Research International 2023; 165 doi: 10.1016/j.foodres.2022.112376
|
| 53 |
Lourianne Nascimento Cavalcante, Jun Porto, Daniel Mazo, Adhemar Longatto-Filho, José Tadeu Stefano, Andre Castro Lyra, Flair Jose Carrilho, Rui Manuel Reis, Venâncio A.F. Alves, Arun J. Sanyal, Claudia P Oliveira. African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population. Annals of Hepatology 2022; 27(6) doi: 10.1016/j.aohep.2022.100728
|
| 54 |
Manush Saydmohammed, Anupma Jha, Vineet Mahajan, Dillon Gavlock, Tong Ying Shun, Richard DeBiasio, Daniel Lefever, Xiang Li, Celeste Reese, Erin E Kershaw, Vijay Yechoor, Jaideep Behari, Alejandro Soto-Gutierrez, Larry Vernetti, Andrew Stern, Albert Gough, Mark T Miedel, D Lansing Taylor. Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors. Experimental Biology and Medicine 2021; 246(22) doi: 10.1177/15353702211009228
|
| 55 |
Mojgan Masoodi, Amalia Gastaldelli, Tuulia Hyötyläinen, Enara Arretxe, Cristina Alonso, Melania Gaggini, Julia Brosnan, Quentin M. Anstee, Oscar Millet, Pablo Ortiz, Jose M. Mato, Jean-Francois Dufour, Matej Orešič. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. Nature Reviews Gastroenterology & Hepatology 2021; 18(12) doi: 10.1038/s41575-021-00502-9
|
| 56 |
Janna C. Nawroth, Debora B. Petropolis, Dimitris V. Manatakis, Tengku Ibrahim Maulana, Gabriel Burchett, Katharina Schlünder, Anke Witt, Abhishek Shukla, Konstantia Kodella, Janey Ronxhi, Gauri Kulkarni, Geraldine Hamilton, Ekihiro Seki, Shelly Lu, Katia C. Karalis. Modeling alcohol-associated liver disease in a human Liver-Chip. Cell Reports 2021; 36(3) doi: 10.1016/j.celrep.2021.109393
|
| 57 |
Joana RIGOR, Maria E. MARTINS, Beatriz PASSOS, Raquel OLIVEIRA, Daniela MARTINS-MENDES. Noninvasive tools for the assessment of fibrosis in metabolic dysfunction-associated steatotic liver disease. Minerva Medica 2024; 115(6) doi: 10.23736/S0026-4806.24.09290-5
|
| 58 |
Manuel Romero-Gómez, Javier Escalada, Mar Noguerol, Antonio Pérez, Juana Carretero, Javier Crespo, Juan J. Mascort, Ignacio Aguilar, Francisco Tinahones, Pedro Cañones, Ricardo Gómez-Huelgas, Daniel de Luis, Idoia Genúa Trullos, Rocío Aller, Miguel A. Rubio, José Luis Calleja. Corrigendum. Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis. Gastroenterología y Hepatología (English Edition) 2026; 49(5) doi: 10.1016/j.gastre.2026.502639
|
| 59 |
Da Hye Yoon, Joo Yun Kim, Heo Keon, Hyeon Gyu Lee, Kunho Seo, Jae-Jung Shim, Jung-lyoul Lee, Hyunsook Kim. Effects of plant-based heat killed lactic acid bacteria and its lithium chloride-extracted cellular protein on high-fat-induced obesity. Journal of Agriculture and Food Research 2024; 15 doi: 10.1016/j.jafr.2024.100965
|
| 60 |
Emma J. Robinson, Matthew C. Taddeo, Xin Chu, Weixing Shi, Craig Wood, Christopher Still, Virginia G. Rovnyak, David Rovnyak. Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted 1H-NMR Metabolomics. Metabolites 2021; 11(11) doi: 10.3390/metabo11110737
|
| 61 |
Dana Goldner, Joel E. Lavine. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges. Gastroenterology 2020; 158(7) doi: 10.1053/j.gastro.2020.01.048
|
| 62 |
G.P. Han, J.H. Kim, J.-M. Kim, D.Y. Kil. Transcriptomic analysis of the liver in aged laying hens with different eggshell strength. Poultry Science 2023; 102(1) doi: 10.1016/j.psj.2022.102217
|
| 63 |
|
| 64 |
Manuel Romero-Gómez, Javier Escalada, Mar Noguerol, Antonio Pérez, Juana Carretero, Javier Crespo, Juan J. Mascort, Ignacio Aguilar, Francisco Tinahones, Pedro Cañones, Ricardo Gómez-Huelgas, Daniel de Luis, Idoia Genúa Trullos, Rocío Aller, Miguel A. Rubio. Guía de práctica clínica multidisciplinar de manejo de la esteatosis hepática metabólica. Gastroenterología y Hepatología 2025; 48(8) doi: 10.1016/j.gastrohep.2025.502442
|
| 65 |
Silvia Sookoian, Carlos J Pirola. Repurposing drugs to target nonalcoholic steatohepatitis. World Journal of Gastroenterology 2019; 25(15): 1783-1796 doi: 10.3748/wjg.v25.i15.1783
|
| 66 |
Lucia Carulli, Giulia Zanca, Filippo Schepis, Erica Villa. RETRACTED: Carulli et al. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019, 9, 25. Metabolites 2019; 9(4) doi: 10.3390/metabo9040070
|
| 67 |
Antonio Cardamone, Anna Rita Coppoletta, Roberta Macrì, Saverio Nucera, Stefano Ruga, Federica Scarano, Rocco Mollace, Annachiara Mollace, Samantha Maurotti, Edoardo Micotti, Cristina Carresi, Vincenzo Musolino, Micaela Gliozzi, Vincenzo Mollace. Targeting leptin/CCL3-CCL4 axes in NAFLD/MAFLD: A novel role for BPF in counteracting thalamic inflammation and white matter degeneration. Pharmacological Research 2024; 209 doi: 10.1016/j.phrs.2024.107417
|
| 68 |
Marvin Martens, Franziska Kreidl, Friederike Ehrhart, Didier Jean, Merlin Mei, Holly M. Mortensen, Alistair Nash, Penny Nymark, Chris T. Evelo, Ferdinando Cerciello. A Community-Driven, Openly Accessible Molecular Pathway Integrating Knowledge on Malignant Pleural Mesothelioma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.849640
|